Please login to the form below

Not currently logged in
Email:
Password:

Aerie Pharmaceuticals appoints new members of its commercialisation team

David Biddell, Shaun Gentry and Erin Horn join the firm

Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.

David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.

Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.

They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.

28th November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics